Phosphatidylinositol-3 kinase inhibitors enhance the anti-leukemia effect of STI571.

被引：0
|
作者：
Klejman, A
Rushen, L
Morrione, A
Slupianek, A
Skorski, T
机构：
[1] Temple Univ, Ctr Biotechnol, Philadelphia, PA 19122 USA
[2] Kimmel Canc Ctr, Philadelphia, PA USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
616
引用
收藏
页码：146A / 146A
页数：1
相关论文
共 50 条
  • [41] The phosphatidylinositol-3 kinase I inhibitor BKM120 induces cell death in B-chronic lymphocytic leukemia cells in vitro
    Amrein, Lilian
    Shawi, May
    Grenier, Jeremy
    Aloyz, Raquel
    Panasci, Lawrence
    INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (01) : 247 - 252
  • [42] Effect of a selective Abl tyrosine kinase inhibitor, STI571, on in vitro growth of BCR-ABL-positive acute lymphoblastic leukemia cells
    Kawaguchi, Y
    Jinnai, I
    Nagai, K
    Yagasaki, F
    Yakata, Y
    Matsuo, T
    Kuriyama, K
    Tomonaga, M
    LEUKEMIA, 2001, 15 (04) : 590 - 594
  • [43] Effect of High Fat Diet-Induced Obesity on Ovarian Phosphatidylinositol-3 Kinase Signaling Pathway Members in Mice.
    Nteeba, Jackson
    Bhattacharya, Poulomi
    Madden, Jill A.
    Stromsdorfer, Kelly
    Perfield, Jim W.
    Keating, Aileen F.
    BIOLOGY OF REPRODUCTION, 2011, 85
  • [44] Effect of a selective Abl tyrosine kinase inhibitor, STI571, on in vitro growth of BCR-ABL-positive acute lymphoblastic leukemia cells
    Y Kawaguchi
    I Jinnai
    K Nagai
    F Yagasaki
    Y Yakata
    T Matsuo
    K Kuriyama
    M Tomonaga
    Leukemia, 2001, 15 : 590 - 594
  • [45] Involvement of phosphatidylinositol-3 kinase-Akt and nuclear factor kappa-B pathways in the effect of frutalin on human lymphocyte
    Brando-Lima, AC
    Saldanha-Gama, RF
    Pereira, CR
    Villela, CG
    Sampaio, ALF
    Monteiro-Moreira, ACO
    Henriques, MDMO
    Moreira, RA
    Barja-Fidalgo, C
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2006, 6 (03) : 465 - 472
  • [46] Curcumin analogue, A13, exhibits anti-leukemia effect via inhibiting STAT3
    Weng, Qiaoyou
    Ren, Luqing
    Guo, Lu
    Hu, Yan
    Zhou, Haixia
    Bao, Yuyan
    Chen, Lingfeng
    Liang, Guang
    Wang, Yi
    Ruan, Jichen
    TUMOR BIOLOGY, 2016, 37 (07) : 9959 - 9966
  • [47] PHOSPHATIDYLINOSITOL-3 KINASE (PI3K) NEED NOT BE TYROSINE PHOSPHORYLATED FOR ITS GROWTH-FACTOR (GF)-STIMULATED CATALYTIC EFFECT
    WEISS, RH
    FASEB JOURNAL, 1993, 7 (07): : A1239 - A1239
  • [48] Anti-leukemia effect of vitamin K3 is mediated through mitochondrial complexes I and II
    Ibrahim, Medhat
    Mendis, Nilmini
    Roma, Alessia
    Jayanth, Preethi
    Minden, Mark D.
    Spagnuolo, Paul A.
    LEUKEMIA & LYMPHOMA, 2019, 60 (12) : 3071 - 3074
  • [49] Marine Cytotoxin Santacruzamate A Derivatives as Potent HDAC1-3 Inhibitors and Their Synergistic Anti-Leukemia Effects with Venetoclax
    Hao, Wanting
    Wang, Leyan
    Xu, Tongqiang
    Jia, Geng
    Jiang, Yuqi
    Qin, Chong
    Li, Xiaoyang
    MARINE DRUGS, 2024, 22 (06)
  • [50] Enhanced anti-cancer effect of a phosphatidylinositol-3 kinase inhibitor and doxorubicin on human breast epithelial cell lines with different p53 and oestrogen receptor status
    Wang, Yan A.
    Johnson, Stuart K.
    Brown, Barry L.
    McCarragher, Leeza M.
    A-Sakkaf, Kaltoom
    Royds, Janice A.
    Dobson, Pauline R. M.
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (07) : 1536 - 1544
12345